A new nanotech-based microchip was able to identify antibodies that indicate the early stages of type 1 diabetes one year earlier in two of six patients who developed diabetes during the study, and four years earlier in one individual, compared with traditional methods that could detect antibodies in the latter stages of diabetes development, according to a study in the journal PLOS ONE. Findings were based on 14 individuals with and without diabetes from the TrialNet study.
Study shows efficacy of microchip in detecting type 1 diabetes
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.